BJL
COLL icon

Brighton Jones LLC’s Collegium Pharmaceutical COLL Stock Holding History

Brighton Jones LLC’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Buy
10,926
+26
+0.2% +$888 0.01% 911
2026
Q1 		$360K Buy
+10,900
New +$461K 0.01% 837
2025
Q4 		– Sell
-10,810
Closed -$378K – 223
2025
Q3 		$378K Buy
10,810
+45
+0.4% +$1.56K 0.01% 730
2025
Q2 		$318K Buy
10,765
+90
+0.8% +$2.57K 0.01% 699
2025
Q1 		$319K Buy
10,675
+22
+0.2% +$672 0.01% 516
2024
Q4 		$305K Sell
10,653
-29
-0.3% -$960 0.01% 515
2024
Q3 		$413K Buy
10,682
+11
+0.1% +$392 0.02% 357
2024
Q2 		$344K Sell
10,671
-100
-0.9% -$3.47K 0.01% 441
2024
Q1 		$418K Buy
10,771
+129
+1% +$4.51K 0.02% 388
2023
Q4 		$328K Hold
10,642
– – 0.01% 425
2023
Q3 		$238K Hold
10,642
– – 0.01% 459
2023
Q2 		$229K Hold
10,642
– – 0.01% 469
2023
Q1 		$255K Hold
10,642
– – 0.01% 418
2022
Q4 		$247K Hold
10,642
– – 0.01% 388
2022
Q3 		$170K Buy
10,642
+49
+0.5% +$864 0.01% 432
2022
Q2 		$188K Sell
10,593
-63
-0.6% -$1.06K 0.01% 436
2022
Q1 		$217K Buy
10,656
+41
+0.4% +$775 0.01% 457
2021
Q4 		$198K Buy
10,615
+22
+0.2% +$429 0.01% 501
2021
Q3 		$209K Hold
10,593
– – 0.01% 447
2021
Q2 		$250K Hold
10,593
– – 0.01% 398
2021
Q1 		$251K Buy
+10,593
New +$252K 0.01% 351

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Brighton Jones LLC's COLL Position: Q2 2026 in Review

Brighton Jones LLC increased its Collegium Pharmaceutical (COLL) stake by 0.24% in Q2 2026, buying an estimated $888 and bringing the position to 10,926 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #911.

Brighton Jones LLC first reported a position in COLL in Q1 2021 and has held it in 21 quarters since. The position peaked at $418K in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Brighton Jones LLC held 10,926 shares of Collegium Pharmaceutical worth $396K as of Q2 2026.
  • Brighton Jones LLC bought 26 Collegium Pharmaceutical shares in Q2 2026, an estimated $888.
  • Collegium Pharmaceutical made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #911 holding.
  • Brighton Jones LLC first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 21 quarters since.
  • Brighton Jones LLC's Collegium Pharmaceutical position peaked at $418K in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.